A. Dennis Ausiello's most recent trade in Seres Therapeutics Inc was a trade of 6,452 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seres Therapeutics Inc | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 6,452 | 6,452 | - | - | Stock Option (right to buy) | |
| Rani Therapeutics Holdings... | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 50,000 | 50,000 | - | - | Director Stock Option (Right to Buy) | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 1,558 | 1,558 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 775 | 911 (0%) | 0% | 0 | Common Stock | |
| Seres Therapeutics Inc | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Rani Therapeutics Holdings... | Dennis A. Ausiello | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2024 | 101,276 | 0 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 101,276 | 101,276 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2024 | 15,423 | 79,317 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Dennis A. Ausiello | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2024 | 15,423 | 0 | - | - | Stock Option (Right to Buy) | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2024 | 11,250 | 0 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 131.21 per share. | 06 Aug 2024 | 11,250 | 11,386 (0%) | 0% | 131.2 | 1,476,113 | Common Stock |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2024 | 9,000 | 0 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 105.26 per share. | 06 Aug 2024 | 9,000 | 20,386 (0%) | 0% | 105.3 | 947,340 | Common Stock |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Sale of securities on an exchange or to another person at price $ 261.63 per share. | 06 Aug 2024 | 6,212 | 8,805 (0%) | 0% | 261.6 | 1,625,246 | Common Stock |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Sale of securities on an exchange or to another person at price $ 262.79 per share. | 06 Aug 2024 | 4,367 | 4,438 (0%) | 0% | 262.8 | 1,147,604 | Common Stock |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Sale of securities on an exchange or to another person at price $ 260.40 per share. | 06 Aug 2024 | 3,742 | 15,017 (0%) | 0% | 260.4 | 974,417 | Common Stock |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Sale of securities on an exchange or to another person at price $ 263.72 per share. | 06 Aug 2024 | 3,408 | 1,030 (0%) | 0% | 263.7 | 898,758 | Common Stock |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Sale of securities on an exchange or to another person at price $ 259.56 per share. | 06 Aug 2024 | 1,627 | 18,759 (0%) | 0% | 259.6 | 422,304 | Common Stock |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Sale of securities on an exchange or to another person at price $ 264.95 per share. | 06 Aug 2024 | 632 | 398 (0%) | 0% | 264.9 | 167,448 | Common Stock |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Sale of securities on an exchange or to another person at price $ 266.45 per share. | 06 Aug 2024 | 262 | 136 (0%) | 0% | 266.5 | 69,810 | Common Stock |
| Seres Therapeutics Inc | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 64,564 | 64,564 | - | - | Stock Option (right to buy) | |
| Rani Therapeutics Holdings... | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 5,228 | 5,228 | - | - | Stock Option (right to buy) | |
| Seres Therapeutics Inc | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Rani Therapeutics Holdings... | A. Dennis Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 101,276 | 101,276 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Ausiello A. Dennis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 101,276 | 0 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | A. Dennis Ausiello | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 15,423 | 63,894 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 15,423 | 15,423 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings... | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 101,276 | 101,276 | - | - | Stock Option (Right to Buy) | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 3,454 | 3,454 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 136 | 136 (0%) | 0% | 0 | Common Stock | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 136 | 0 | - | - | Restricted Stock Units | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Sale of securities on an exchange or to another person at price $ 220.00 per share. | 21 Nov 2022 | 22,500 | 0 (0%) | 0% | 220 | 4,950,000 | Common Stock |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.99 per share. | 21 Nov 2022 | 11,250 | 22,500 (0%) | 0% | 72.0 | 809,888 | Common Stock |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2022 | 11,250 | 0 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2022 | 11,250 | 0 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 70.20 per share. | 21 Nov 2022 | 11,250 | 11,250 (0%) | 0% | 70.2 | 789,750 | Common Stock |
| Seres Therapeutics Inc | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Rani Therapeutics Holdings... | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 41,416 | 41,416 | - | - | Stock Option (Right to Buy) | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 5,153 | 5,153 | - | - | Stock Option (right to buy) | |
| Alnylam Pharmaceuticals Inc | Dennis A. Ausiello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 4,032 | 4,032 | - | - | Stock Option (right to buy) |